Paper30104484
Stealth and Cationic Nanoliposomes as Drug Delivery Systems to Increase Andrographolide BBB Permeability.
Piazzini V and 5 others. Pharmaceutics, 2018. Cited by 48 papers, by iCite.
Cite this record
ConductScience Library. Stealth and Cationic Nanoliposomes as Drug Delivery Systems to Increase Andrographolide BBB Permeability. Papers, record 30104484. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30104484
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Stealth and Cationic Nanoliposomes as Drug Delivery Systems to Increase Andrographolide BBB Permeability.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25461285 | Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice. | Nanomedicine | 2015 | https://conductscience.org/library/papers/25461285 | PubMed |
| 2 | 12164380 | Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. | J Drug Target | 2002 | https://conductscience.org/library/papers/12164380 | PubMed |
| 3 | 28238790 | Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease. | Neurochem Int | 2017 | https://conductscience.org/library/papers/28238790 | PubMed |
| 4 | 22085653 | Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles. | Eur J Pharm Biopharm | 2012 | https://conductscience.org/library/papers/22085653 | PubMed |
| 5 | 24462780 | Strategy to provide a useful solution to effective delivery of dihydroartemisinin: development, characterization and in vitro studies of liposomal formulations. | Colloids Surf B Biointerfaces | 2014 | https://conductscience.org/library/papers/24462780 | PubMed |
| 6 | 29096375 | Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation. | Colloids Surf B Biointerfaces | 2018 | https://conductscience.org/library/papers/29096375 | PubMed |
| 7 | 21872624 | Transport of drugs across the blood-brain barrier by nanoparticles. | J Control Release | 2012 | https://conductscience.org/library/papers/21872624 | PubMed |
| 8 | 9588866 | Surface-modified amikacin-liposomes: organ distribution and interaction with plasma proteins. | J Drug Target | 1998 | https://conductscience.org/library/papers/9588866 | PubMed |
| 9 | 11300874 | High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. | J Med Chem | 2001 | https://conductscience.org/library/papers/11300874 | PubMed |
| 10 | 25788348 | Preparation and characterization of solid lipid nanoparticle-based nasal spray of budesonide. | Drug Deliv Transl Res | 2013 | https://conductscience.org/library/papers/25788348 | PubMed |
| 11 | 26746802 | Andrographolide stimulates p38 mitogen-activated protein kinase-nuclear factor erythroid-2-related factor 2-heme oxygenase 1 signaling in primary cerebral endothelial cells for definite protection against ischemic stroke in rats. | Transl Res | 2016 | https://conductscience.org/library/papers/26746802 | PubMed |
| 12 | 19013850 | The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies. | J Neurochem | 2008 | https://conductscience.org/library/papers/19013850 | PubMed |
| 13 | 25524173 | Andrographolide reduces cognitive impairment in young and mature AβPPswe/PS-1 mice. | Mol Neurodegener | 2014 | https://conductscience.org/library/papers/25524173 | PubMed |
| 14 | 15896933 | Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain? | Int J Pharm | 2005 | https://conductscience.org/library/papers/15896933 | PubMed |
| 15 | 10640577 | Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. | J Control Release | 2000 | https://conductscience.org/library/papers/10640577 | PubMed |
| 16 | 27002395 | Development of Blood-Brain Barrier Permeable Nanoparticles as Potential Carriers for Salvianolic Acid B to CNS. | Planta Med | 2017 | https://conductscience.org/library/papers/27002395 | PubMed |
| 17 | 21147220 | In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery. | Eur J Pharm Biopharm | 2011 | https://conductscience.org/library/papers/21147220 | PubMed |
| 18 | 26690333 | Dual drug loaded nanoliposomal chemotherapy: A promising strategy for treatment of head and neck squamous cell carcinoma. | Eur J Pharm Biopharm | 2016 | https://conductscience.org/library/papers/26690333 | PubMed |
| 19 | 12711162 | Interactions of amphiphilic calix[4]arene-based Solid Lipid Nanoparticles with bovine serum albumin. | Int J Pharm | 2003 | https://conductscience.org/library/papers/12711162 | PubMed |
| 20 | 10554098 | Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. | Pharm Res | 1999 | https://conductscience.org/library/papers/10554098 | PubMed |
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42168994 | Nanomedicine strategies for overcoming the blood-brain barrier in central nervous system drug delivery: mechanisms, advances, and challenges. | Biomed Eng Online | 2026 | https://conductscience.org/library/papers/42168994 | PubMed |
| 41226236 | Andrographolide and Its Derivatives: A Comprehensive Review of Anti-Infective Properties and Clinical Potential. | Molecules | 2025 | https://conductscience.org/library/papers/41226236 | PubMed |
| 40363835 | Synthesis and Biological Evaluation of Novel Ramalin Derivatives as Multi-Target Agents for Alzheimer's Disease. | Molecules | 2025 | https://conductscience.org/library/papers/40363835 | PubMed |
| 39832031 | Nanoparticle Interactions with the Blood Brain Barrier: Insights from Drosophila and Implications for Human Astrocyte Targeted Therapies. | Neurochem Res | 2025 | https://conductscience.org/library/papers/39832031 | PubMed |
| 39770065 | Cationic Micelle-like Nanoparticles as the Carrier of Methotrexate for Glioblastoma Treatment. | Molecules | 2024 | https://conductscience.org/library/papers/39770065 | PubMed |
| 39125929 | Fungicide-Loaded Liposomes for the Treatment of Fungal Diseases in Agriculture: An Assessment of Botrytis cinerea. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39125929 | PubMed |
| 38931887 | Nanoliposomes Permeability in a Microfluidic Drug Delivery Platform across a 3D Hydrogel. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38931887 | PubMed |
| 38193927 | Functionalized Nanomaterials Capable of Crossing the Blood-Brain Barrier. | ACS Nano | 2024 | https://conductscience.org/library/papers/38193927 | PubMed |
| 37631236 | Induced Vascular Normalization-Can One Force Tumors to Surrender to a Better Microenvironment? | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37631236 | PubMed |
| 37440909 | Novel wine in an old bottle: Preventive and therapeutic potentials of andrographolide in atherosclerotic cardiovascular diseases. | J Pharm Anal | 2023 | https://conductscience.org/library/papers/37440909 | PubMed |
| 37242757 | Antinociceptive Action of Thymoquinone-Loaded Liposomes in an In Vivo Model of Tendinopathy. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37242757 | PubMed |
| 36873538 | PEGylated liposomes enhance the effect of cytotoxic drug: A review. | Heliyon | 2023 | https://conductscience.org/library/papers/36873538 | PubMed |
| 36839768 | Parenteral Lipid-Based Nanoparticles for CNS Disorders: Integrating Various Facets of Preclinical Evaluation towards More Effective Clinical Translation. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36839768 | PubMed |
| 36297480 | Internal Mammary Arteries as a Model to Demonstrate Restoration of the Impaired Vasodilation in Hypertension, Using Liposomal Delivery of the CYP1B1 Inhibitor, 2,3',4,5'-Tetramethoxystilbene. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36297480 | PubMed |
| 35543534 | Pathogenic mechanisms and therapeutic promise of phytochemicals and nanocarriers based drug delivery against radiotherapy-induced neurotoxic manifestations. | Drug Deliv | 2022 | https://conductscience.org/library/papers/35543534 | PubMed |
| 34350048 | Recent advances with liposomes as drug carriers for treatment of neurodegenerative diseases. | Biomed Eng Lett | 2021 | https://conductscience.org/library/papers/34350048 | PubMed |
| 33946703 | Advances in Nano-Enabled Platforms for the Treatment of Depression. | Polymers (Basel) | 2021 | https://conductscience.org/library/papers/33946703 | PubMed |
| 33019651 | The Role of Natural Compounds and their Nanocarriers in the Treatment of CNS Inflammation. | Biomolecules | 2020 | https://conductscience.org/library/papers/33019651 | PubMed |
| 32971917 | Self-Assembly of Amphiphilic Compounds as a Versatile Tool for Construction of Nanoscale Drug Carriers. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32971917 | PubMed |
| 32038141 | Overview of Crosstalk Between Multiple Factor of Transcytosis in Blood Brain Barrier. | Front Neurosci | 2019 | https://conductscience.org/library/papers/32038141 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| APOE | 348 | PubTator's text mining | https://conductscience.org/library/genes/348 | NCBI Gene |
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| FGF2 | 2247 | PubTator's text mining | https://conductscience.org/library/genes/2247 | NCBI Gene |
| LDLR | 3949 | PubTator's text mining | https://conductscience.org/library/genes/3949 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
| PGP | 283871 | PubTator's text mining | https://conductscience.org/library/genes/283871 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30104484
GET https://conductscience.org/api/papers/v1/30104484/references?page=2